Suspension of trading
Quotes LAVA Therapeutics
Stocks
LVTX
NL0015000AG6
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.740 USD | -3.87% |
|
-.--% | - |
| 11-21 | Xoma Royalty Completes Acquisition of Lava Therapeutics | MT |
| 11-21 | Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V. | RE |
Performance
| 1 day | -3.87% | ||
| 1 year | +13.73% | ||
| 3 years | -3.33% | ||
| 5 years | -69.20% |
Volumes
marketsDaily volume
285,521
Estimated daily volume
285,521
Record volume 1
44,648,010
Record volume 2
43,378,213
Record volume 3
36,886,664
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
45,771,213
Net sales ()
12
Number of employees
10
Sales / Employee ()
1
Sales / Employee (USD)
1
Free-Float
83.62 %
Free-Float capitalization (USD)
38,271,634
Indicators
Moving average 5 days
1.748
Moving average 100 days
1.538
Price spread / (MMA5)
+0.43%
Price spread / (MMA100)
-11.60%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.87% | -.--% | +13.73% | -3.33% | 45.77M | ||
| +0.31% | +2.25% | +5.84% | +15.00% | 49.47B | ||
| +3.71% | +9.40% | +486.14% | +592.61% | 43.97B | ||
| +5.60% | +10.21% | +20.85% | +73.63% | 39.6B | ||
| +2.70% | +1.57% | +32.71% | +9.15% | 39.29B | ||
| +2.21% | +6.75% | +20.20% | +47.53% | 32.43B | ||
| +2.23% | +4.71% | - | - | 16.84B | ||
| +0.97% | +2.35% | +35.99% | +122.50% | 16.49B | ||
| -0.46% | +2.57% | +4.86% | +17.84% | 14.01B | ||
| +0.75% | +15.04% | +79.84% | +23.95% | 12.77B | ||
| Average | +1.42% | +5.69% | +77.80% | +99.88% | 26.49B | |
| Weighted average by Cap. | +2.40% | +6.10% | +105.26% | +137.83% |
Historical Quotes: LAVA Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 year | 1.4 | 1.82 | |
| 3 years | 0.85 | 6.47 | |
| 5 years | 0.85 | 8.38 | |
| 10 years | 0.85 | 17.2 |
Monthly variations
Annual variations
| 2025 | +82.97% | ||
| 2024 | -39.81% | ||
| 2023 | -54.86% | ||
| 2022 | -36.36% | ||
| 2021 | -61.54% |
- Stock Market
- Stocks
- LVTX Stock
- Quotes LAVA Therapeutics
Select your edition
All financial news and data tailored to specific country editions
















